Bosnia and Herzegovina vs Oman: Amphetamine use disorder deaths by sex
Bosnia and Herzegovina
0.03 deaths
in 2021
Oman
0.03 deaths
in 2021
Bosnia and Herzegovina rank
135th
Oman rank
135th
Amphetamine use disorder deaths by sex over time
- Bosnia and Herzegovina
- Oman
How they compare
Bosnia and Herzegovina currently reports 0.03 deaths against 0.03 deaths in Oman, a difference of 0 deaths.
The two have swapped places 3 times across 22 shared years of data; in 2000 it was Bosnia and Herzegovina ahead.
Bosnia and Herzegovina ranks 135th and Oman ranks 135th of 194 countries.
Across the 3 decades both report, Bosnia and Herzegovina averaged higher in 2 and Oman in 1.
Head to head by decade
| Decade | Bosnia and Herzegovina | Oman | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0.057 deaths | 0.048 deaths | 0.009 deaths | Bosnia and Herzegovina |
| 2010s | 0.05 deaths | 0.047 deaths | 0.003 deaths | Bosnia and Herzegovina |
| 2020s | 0.03 deaths | 0.035 deaths | 0.005 deaths | Oman |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher amphetamine use disorder deaths by sex, Bosnia and Herzegovina or Oman?
- Bosnia and Herzegovina, at 0.03 deaths against 0.03 deaths in Oman as of 2021.
- What is the difference in amphetamine use disorder deaths by sex between Bosnia and Herzegovina and Oman?
- 0 deaths, with Bosnia and Herzegovina ahead.
- How many years of comparable data are there for Bosnia and Herzegovina and Oman?
- 22 years are reported by both, from 2000 to 2021.
- How do Bosnia and Herzegovina and Oman rank globally for amphetamine use disorder deaths by sex?
- Bosnia and Herzegovina ranks 135th and Oman ranks 135th of 194 countries.
- Where does this data come from?
- World Health Organization (2024) – with major processing by Our World in Data, published as Amphetamine use disorder deaths by sex. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Estimated number of deaths from amphetamine use disorders in females.